CAS 36019-33-7

Lividamine

CAS : 36019-33-7

Lividamine is a protein synthesis inhibitor that has biphasic responses in animal studies. Lividamine inhibits the enzyme catalysis of aminoglycosides, which are used for the treatment of bacterial infections. It also blocks the biosynthesis of polypeptides, which are essential for cell growth and division. Lividamine binds to the hydroxyl group or carboxylate group on an amino acid, cleaving it from the peptide chain and stopping protein synthesis. Lividamine has been shown to be effective against bacteria in vitro assays. Further research is required to determine its clinical properties.

Formule : C₁₂H₂₅N₃O₆

Degré de pureté : Min. 95%

Masse moléculaire : 307.34 g/mol

Ref: 3D-OL46088